Nanobiotechnology and Nanomedicine Companies

The firm commercializes a family of self-assembling nanoscale scaffolds called PuraMatrix. 3DM's materials assemble upon injection into nanofibers, serving as a scaffold for tissue regeneration.

The company develops biomedical nanoparticle technology and products for research and treatment of human disease. They are developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers.

The company has developed enabling nanotechnologies for the production of protein nanoparticles, polymer nanospheres and phospholipid nanosomes for the enhanced delivery of drugs.

Develops a nanostructured material that stops bleeding almost instantly.

Arrayit Corporation empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

Develops a family of nanocomposite materials designed to increase mechanical performance in medical applications.

Nanofiber Solutions designs and manufactures novel 3D nanofiber scaffolds. The company's 3D cell culture products NanoAligned and NanoECM were developed for life science research. Nanofiber Solutions novel platform technology provides researchers with more biologically realistic 3-dimensional in vivo cell culture environment.

Design, synthesis, and analysis of small molecule organic compounds for the pharmaceutical industry.

Novavax is focused on creating novel, highly potent recombinant vaccines produced via cell culture. The company has developed three proprietary technology platforms: Virus-Like Particles, Novasome� paucilamellar vesicles and Micellar Nanoparticles.

Parabon NanoLabs designs and develops a new class of therapeutics and other products made possible by proprietary technology for precisely directing the self-assembly of designer macromolecules that are functionalized with molecular subcomponents (e.g., enzymes, metals or pharmaceuticals).

Particle Sciences is an integrated provider of both standard and nanotechnology approaches to drug development and delivery. The company originally pioneered use of encapsulated ingredients and nanoparticles for sunscreens and personal care. In 1999 the company licensed a portion of its nanotechnology portfolio to BASF and focused its efforts on providing services to Life Sciences companies. Now, through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution designed to minimize the time and risk between discovery and the clinic.

The company developed the Artiste™ Nano Composite System for dental restoration.

The company develops, produces and markets nanotechnologies for the life sciences. They produce a variety of nano-structured surfaces for use in research and are also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions.

Develops, manufactures, and sells a broad range of biological based materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of therapeutic drugs,including clinically annotated DNA and RNA.

Developed and manufactures a novel, biomaterial which utilizes hydrogel nanoparticles which aggregate to form a material of varying strength and elasticity which has extensive medical application including wound management and burn care, tissue regeneration and drug delivery devices.